G. Kees HovinghMD, PhD, MBA
Dr G.K. Hovingh (1974) has been appointed professor of Internal Medicine, with a focus on the molecular genesis and treatment of atherosclerosis, at the University of Amsterdam’s Faculty of Medicine (AMC-UvA).
In his research, Kees Hovingh concentrates on the genesis of cardiovascular diseases and on therapies for patients with cardiovascular ailments, especially disorders of cholesterol metabolism. His main focus is on patients with familial hypercholesterolemia, a hereditary condition characterised by an excessive blood level of LDL cholesterol which leads to premature cardiovascular disease.
Hovingh is the founder of an international network of specialists treating patients with homozygous Familial Hypercholesterolemia (hoFH), a rare form of FH. These patients sometimes experience a heart attack as early as the age of twenty. Together with colleagues Hovingh is evaluating new lipid lowering therapies, and he does this with his international colleagues.